No Evidence of QT Prolongation With Supratherapeutic Doses of Aleglitazar

Title
No Evidence of QT Prolongation With Supratherapeutic Doses of Aleglitazar
Authors
Keywords
-
Journal
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
Volume 59, Issue 3, Pages 288-297
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-11-22
DOI
10.1097/fjc.0b013e3182411e67

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started